ArticleBiomedicines2026

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib.

Gabriela Ribeiro Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.